Home  >  News
  Health Canada approves BioDelivery Sciences' Belbuca for management of pain,   June 26, 2017
  US FDA approves Genentech's Rituxan Hycela in combo with Halozyme's Enhanze technology for multiple blood cancer indications,   June 24, 2017
  US FDA approves CSL Behring's subcutaneous C1 esterase inhibitor, Haegarda to treat rare genetic disease,   June 24, 2017
  Novartis receives US FDA nod for Tafinlar in combo with Mekinist for BRAF V600E mutant metastatic NSCLC,   June 24, 2017
  Shire receives US FDA approval for Mydayis, a new once-daily option for ADHD symptom control in patients 13 years and older,   June 22, 2017
  Seattle Genetics seeks US FDA approval for Adcetris in cutaneous T-cell lymphoma,   June 22, 2017
  US FDA committee votes in favour of Novo Nordisk's Victoza for reducing cardiovascular risk in patients with type 2 diabetes,   June 22, 2017
  Neos receives US FDA approval of Cotempla XR-ODT tablets to treat patients with ADHD,   June 21, 2017
  Sonoma Pharma receives Singapore approvals for EZyma Hydrogel for atopic dermatitis & ScarLess Hydrogel for hypertrophic/keloid scars,   June 21, 2017
  US FDA accepts Amgen's sBLA to expand indication for Xgeva to include MM patients,   June 21, 2017
  NCCN guidelines for NET include Xermelo in combo with SSA therapy as recommended treatment option for carcinoid syndrome diarrhea,   June 20, 2017
  Axovant Sciences receives US FDA fast track status for nelotanserin to treat visual hallucinations in DLB,   June 20, 2017
  Sandoz receives European approval for Rixathon to treat blood cancers & immunological diseases,   June 20, 2017
  US FDA approves Darzalex in combo with pomalidomide & dexamethasone for patients with multiple myeloma who have received at least 2 prior therapies,   June 19, 2017
  RASRx receives US FDA orphan drug status for RASRx1902 to treat Duchenne Muscular Dystrophy,   June 17, 2017
  Immune Pharma signs agreement with Meda to regain Ceplene's European & Asian rights,   June 17, 2017
  Sandoz announces US FDA accepts its ANDA for generic version of Advair Diskus,   June 17, 2017
  Johnson & Johnson acquires Actelion for $30 billion,   June 16, 2017
  Venus Medtech buys US-based balloon aortic valvuloplasty products supplier, InterValve,   June 16, 2017
  Sanofi launches worldwide employee stock purchase plan, “Action 2017”,   June 15, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |